Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients.
about
Fixed-dose single tablet antidiabetic combinationsInfluence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort studyComparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling.Self-report of current and prior antiretroviral drug use in comparison to the medical record among HIV-infected patients receiving primary HIV care.Adherence to oral anti-diabetic drugs among patients attending a Ghanaian teaching hospital.Adherence to oral therapy for type 2 diabetes: opportunities for enhancing glycemic control.Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.Towards single-tablet therapy for type 2 diabetes mellitus. Rationale and recent developments.Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration.The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.Adjuvant hormonal therapy use among insured, low-income women with breast cancer.The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups.Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care.Patient adherence to medication requirements for therapy of type 2 diabetes.Diabetes-science, serendipity and common sense.Fixed-dose combinations for treatment of type 2 diabetes mellitus.Individualized treatment of type 2 diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician.Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.Identifying and Prioritizing the Barriers and Facilitators to the Self-Management of Type 2 Diabetes Mellitus: A Community-Centered Approach.Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes.Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration.Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas.Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study).Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.Assessing barriers to medication adherence in underserved patients with diabetes in Texas.Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India.
P2860
Q22242410-248421E6-4CD8-4652-8548-286F3D86F3D3Q33754547-68949AEE-2F26-4C7F-B147-CB1EA5D6F937Q34065562-FA0AA5D9-23CA-4EB4-90EE-256C1C215BB3Q35055716-F49CDFF2-F9F9-473A-AF0C-249CDE9D9E54Q35257188-E0063042-89DF-4F91-A45E-D62FF31B1ED4Q35685331-E31D886C-885B-419F-8EBF-E8793BED8B2AQ35783714-F0B52107-610A-496C-BE45-B3B9FEF5E83AQ35871799-7060C1B6-DF17-4AF5-98DD-5669B7982E3FQ36130198-5771B256-CF0B-4A8F-8A0B-CB55C68AC6A6Q36432150-E4276468-0899-4BBE-9008-C39E6944D458Q37280714-9C2858C3-77F3-463A-8014-3F60032A1613Q37502682-C86227FA-B6C8-4A0E-A490-FAB9B9E1A525Q37773452-74ED4044-F8FA-4B38-AC07-C2D81ADACE29Q37840269-20A41EE9-3985-4058-A842-CC52E1822123Q37910966-07D10C2C-9884-4598-B33D-4C8F05AED5B6Q37978206-CD194086-407E-4C04-AD4C-795A0DBDBEB7Q38036773-311B210E-9B4F-42BB-A9F8-DF4F43B4E399Q38599975-AD6AB06F-37AE-4C8B-BA18-FA2CF6F7EE25Q38783100-5AFAB392-3419-4541-88CF-9DACBAA0F8D1Q39044561-CA5B6764-8493-49CC-8DAA-5AE78AE4A8DBQ40681506-1FA8E8B6-0DB8-4AC9-9C8E-CB2D5D92F482Q40756010-0BC5F0E6-37BA-4C6E-A3DB-8709CB41DE41Q43187617-8C197C80-A82B-4FA5-9B77-21D5553C6766Q44655649-4CA8F537-5900-41D2-A4B1-533D7C070895Q45063950-28AFD7F4-3424-490B-AB8A-C302E9E50258Q45141340-8A50ED23-3490-4D30-BE47-EAFEC9393133Q45923461-C7ACB96B-6388-41E7-A34B-DE5446F8238AQ52661640-0477D062-00B7-49D0-9ADE-88FA14D12202
P2860
Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Patient compliance and persist ...... n of type 2 diabetic patients.
@en
Patient compliance and persist ...... n of type 2 diabetic patients.
@nl
type
label
Patient compliance and persist ...... n of type 2 diabetic patients.
@en
Patient compliance and persist ...... n of type 2 diabetic patients.
@nl
prefLabel
Patient compliance and persist ...... n of type 2 diabetic patients.
@en
Patient compliance and persist ...... n of type 2 diabetic patients.
@nl
P2093
P1476
Patient compliance and persist ...... n of type 2 diabetic patients.
@en
P2093
P2860
P356
10.1177/147323000203000111
P577
2002-01-01T00:00:00Z